ABSTRACT
No disponible
Subject(s)
Humans , Male , Aged, 80 and over , Omentum/physiopathology , Infarction/physiopathology , Abdomen, Acute/etiology , Heart Block/complications , Infarction/diagnostic imagingSubject(s)
Abdomen, Acute/etiology , Infarction/complications , Omentum/blood supply , Aged, 80 and over , Humans , MaleABSTRACT
La apatía es un trastorno de la motivación consistente en una reducción cuantitativa de la conducta dirigida a objetivos. Los pacientes muestran una pérdida de motivación, preocupación, interés y respuesta emocional, lo que se traduce en una disminución de la iniciativa, de la interacción con el entorno y de la actividad social. La apatía no solo es frecuente tras el ictus sino que su presencia afecta negativamente a pacientes y cuidadores, incluyendo una peor recuperación funcional, pérdida de la autonomía social y mayor sobrecarga del cuidador. Es necesario disponer de una definición precisa y de unos criterios diagnósticos consensuados de apatía para mejorar la valoración e individualizar el plan de tratamiento del paciente. Así como las terapias de modificación de conducta han demostrado su utilidad, son escasos los ensayos clínicos dirigidos a evaluar la eficacia del tratamiento farmacológico de pacientes con apatía postictus (AU)
Apathy is a motivational disturbance that can be defined as a quantitative reduction of goal-directed behaviour. Patients present with loss of motivation, concern, interest, and emotional response, resulting in a loss of initiative, decreased interaction with their environment, and a reduced interest in social life. Apathy not only appears to be common in stroke patients, but it has also been related to a wide range of negative consequences for the patients and their caregivers, including poor functional recovery, loss of social independence, and caregiver distress. Clear definition and consensus diagnostic criteria for apathy are needed to accomplish an accurate assessment and an individualised treatment plan. Although there have been reports of successful behavioural therapy treatment of apathetic states, there is a paucity of controlled clinical trials on the efficacy of apathetic behaviours using pharmacotherapy (AU)
Subject(s)
Humans , Male , Female , Aged , Aged, 80 and over , Apathy/physiology , Apathy , Motivation , Expressed Emotion/physiology , Stroke/complications , Stroke/drug therapy , Basal Ganglia , Basal Ganglia/pathology , Prefrontal Cortex , Prefrontal Cortex/pathology , Cognitive Aging/psychology , Risk Factors , Depression/complicationsABSTRACT
Apathy is a motivational disturbance that can be defined as a quantitative reduction of goal-directed behaviour. Patients present with loss of motivation, concern, interest, and emotional response, resulting in a loss of initiative, decreased interaction with their environment, and a reduced interest in social life. Apathy not only appears to be common in stroke patients, but it has also been related to a wide range of negative consequences for the patients and their caregivers, including poor functional recovery, loss of social independence, and caregiver distress. Clear definition and consensus diagnostic criteria for apathy are needed to accomplish an accurate assessment and an individualised treatment plan. Although there have been reports of successful behavioural therapy treatment of apathetic states, there is a paucity of controlled clinical trials on the efficacy of apathetic behaviours using pharmacotherapy.
